AP2B1 Knockout HeLa Polyclonal Cells are a heterogeneous pool of HeLa cells engineered with CRISPR/Cas9-mediated disruption of the AP2B1 gene, which encodes the beta-1 subunit of the adaptor protein complex 2 (AP-2). This polyclonal knockout population eliminates functional AP2B1 protein, providing a robust loss-of-function model for dissecting clathrin-mediated endocytosis and intracellular trafficking pathways. Unlike clonal cell lines, the polyclonal format preserves genetic diversity within the knockout background, enabling broad assessment of phenotypic consequences without clonal artifacts.
The parental HeLa cell line is a widely studied human cervical adenocarcinoma line containing integrated human papillomavirus 18 (HPV-18) DNA. Its aneuploidy, immortalized growth, and robust expression of endocytic machinery make it an ideal host for investigating membrane trafficking in a cancer context. HeLa cells have been instrumental in elucidating mechanisms of receptor-mediated endocytosis, signal transduction, and viral entry, rendering them highly suitable for interrogating AP2B1 function.
AP2B1 is a core component of the heterotetrameric AP-2 adaptor complex, which also includes AP2A1/AP2A2 (??), AP2M1 (??2), and AP2S1 (??2). This complex is recruited to the plasma membrane by phosphatidylinositol-4,5-bisphosphate (PIP2) and cargo receptors, where it orchestrates clathrin coat assembly. AP2B1 is regulated by phosphorylation via adaptor-associated kinase 1 (AAK1) and cyclin G-associated kinase (GAK) and interacts with clathrin, endocytic accessory proteins Eps15 and epsin, and the ?? and ??2 subunits to link cargo to the clathrin lattice. Consequently, AP2B1 knockout disrupts the internalization of key receptors, including epidermal growth factor receptor (EGFR), transferrin receptor (TfR), low-density lipoprotein receptor (LDLR), and various G protein-coupled receptors (GPCRs), thereby perturbing downstream signaling cascades and membrane protein homeostasis.
In HeLa cells, loss of AP2B1 profoundly alters receptor trafficking dynamics. Because HeLa cells express EGFR, TfR, and other cargo receptors, this knockout model enables direct evaluation of how defective endocytosis reshapes oncogenic signaling networks. The aneuploid, HPV-positive background further provides a relevant environment for studying the interplay between endocytic pathways and cancer cell biology, including altered growth factor signaling, nutrient uptake, and potential impacts on viral entry processes.
This product is suited for a wide range of experimental applications, including the analysis of clathrin-mediated endocytosis, receptor recycling and degradation, and drug delivery mechanisms. Researchers can utilize transferrin uptake assays, EGFR internalization kinetics, immunofluorescence microscopy of endocytic markers, co-immunoprecipitation of AP-2 complex components, and flow cytometric quantification of surface receptor levels. These assays facilitate investigations into how AP2B1 disruption influences cell proliferation, survival, and therapeutic sensitivity. For technical inquiries, please contact Ascent Research.
